Search Result "vulnerability."


Genetic Chemoprotection with Mutant O6-Alkylguanine-DNA-Alkyltransferases

Journal: Current Gene Therapy
Volume: 2 Issue: 1 Year: 2002 Page: 1-8
Author(s): D. A. Hobin, L. J. Fairbairn

Depressed or Demented: Common CNS Drug Targets? !

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1 Issue: 6 Year: 2002 Page: 575-592
Author(s): Miao-Kun Sun, Daniel L. Alkon

Glutamate and Schizophrenia: Pathophysiology and Therapeutics

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 2 Issue: 1 Year: 2002 Page: 29-44
Author(s): G. J. Marek

Alzheimers Disease: Targets For Drug Development

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 2 Issue: 1 Year: 2002 Page: 1-9
Author(s): Andrew J. Larner

Chronic Tendon Pain: No Signs of Chemical Inflammation but High Concentrations of the Neurotransmitter Glutamate. Implications for Treatment?

Journal: Current Drug Targets
Volume: 3 Issue: 1 Year: 2002 Page: 43-54
Author(s): Hakan Alfredson, Ronny Lorentzon

Chips for Brains

Journal: Current Genomics
Volume: 3 Issue: 1 Year: 2002 Page: 1-5
Author(s): D. J. Smith

Benzodiazepine Discontinuation Difficulties in Panic Disorder: Conceptual Model and Outcome for Cognitive-Behavior Therapy

Journal: Current Pharmaceutical Design
Volume: 8 Issue: 1 Year: 2002 Page: 75-80
Author(s): M. W. Otto, J. J. Hong, S. A. Safren

5-Lipoxygenase in the Central Nervous System: Therapeutic Implications

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 1 Issue: 2 Year: 2002 Page: 115-121
Author(s): Hari Manev, Tolga Uz

Journal: Current Gene Therapy
Volume: 2 Issue: 4 Year: 2002 Page: 451-483
Author(s): L. Tenenbaum, A. Chtarto, E. Lehtonen, D. Blum, V. Baekelandt, T. Velu, J. Brotchi, M. Levivier

Previous   Next

Go To   Results 1 - 1 of 26

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy